×

Syahriel Abdullah, Researcher / Lecturer, Universiti Malaysia Sabah (UMS)

Dr. Syahriel Abdullah is a Senior Lecturer at the Institute for Tropical Biology and Conservation (ITBC), Universiti Malaysia Sabah (UMS), where he leads strategic research initiatives at the intersection of tropical biodiversity and advanced drug development. Based in Borneo, a global biodiversity ...

Close Full biography

Syahriel Abdullah, Researcher / Lecturer, Universiti Malaysia Sabah (UMS)

Roberto Adamo, Vaccine Development Leader, GSK

×

Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center

Prasad Adusumilli is a thoracic surgeon-scientist and Vice Chair of Translational Research in Dept. of Surgery at the Memorial Sloan Kettering Cancer Center, New York. His research focuses on solid tumor immunology and immunotherapy. Supported by R01 and Dept of Defense awards, his laboratory...

Close Full biography

Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center

×

Alsya Affandi, Lead Scientist, CSO Immunara, Amsterdam UMC

Alsya Affandi is a Lead Scientist at Amsterdam UMC and Chief Scientific Officer (CSO) at Immunara, an academic spinout, with a strong background in immunology. He focuses on harnessing antigen-presenting cell biology for next-generation biologic therapies, with an emphasis on improving anti-tumor...

Close Full biography

Alsya Affandi, Lead Scientist, CSO Immunara, Amsterdam UMC

Josephine Alba, Senior expert I data science, Novartis

×

Khalid Al-Kinani, Professor and Dept. Chair, University of Baghdad

Khalid Al-Kinani is a distinguished Professor and Department Chair at the University of Baghdad, renowned for his expertise in the field of biologics. He also serves as a mamber of the 2nd Medicines Reguistration Committee at the Iraqi Ministry of Health (MOH) and a former Head of Biologics and...

Close Full biography

Khalid Al-Kinani, Professor and Dept. Chair, University of Baghdad

Manal Almutairi, Senier expert clinical assessor, SFDA

Jörg Altekrüger, Director Drug Substance Development, Novartis Pharma AG

×

Antonio Angelastro, Senior Scientist, AstraZeneca

Antonio is a Senior Scientist in AstraZeneca’s Biologics Engineering—Protein Engineering and New Modalities division, specialising in pre-clinical biopharmaceutical development. His expertise lies in bioconjugation chemistry and the design of advanced protein conjugates, helping to shape innovative ...

Close Full biography

Antonio Angelastro, Senior Scientist, AstraZeneca

Jean-Philippe Annereau, CEO, Medetia Pharmaceuticals

Marcelino Arciniega Castro, Head of Structural Biology and Data Analysis, JJP Biologics

×

Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc

Philip M. Arlen, M.D., President and Chief Executive Officer: Dr. Arlen spent 11 years at the National Cancer Institute, USA, most recently as the Director of the Clinical Research Group for the Laboratory of Tumor Immunology and Oncology. At the NCI, Dr. Arlen focused on the development of a...

Close Full biography

Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc

×

Baptiste Balbuena, Application Engineer Downstream, Merck Group

Baptiste Balbuena is a Biomanufacturing Engineer MSAT EMEA passioned by bioprocessing. Holder of a master’s degree in project management and biotechnologies innovation from Montpellier University, he dedicated last years to technically support customers with various problematics concerning...

Close Full biography

Baptiste Balbuena, Application Engineer Downstream, Merck Group

Jitin Bali, Business Development Manager, Numaferm GmbH

Abhishek Bansod, Senior Safety Scientist, Roche

Ricardo Baptista, CTO, Ricardo Baptista - SmartCella

×

Umberto Maria Battisti, Associate Professor, University of Copenhagen

Dr. Umberto Maria Battisti is a medicinal and radiochemist with over 10 years of experience. From 2018 to 2026, he served as Assistant and then Associate Professor in the Department of Medicinal Chemistry at the University of Copenhagen, focusing on bioorthogonal chemistry for in vivo PET imaging...

Close Full biography

Umberto Maria Battisti, Associate Professor, University of Copenhagen

Cornelia Baumgartner, Clinical Operations Manager, T-CURX GmbH

×

Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre

Dr Alain Beck is Senior Director, Biologics CMC and Developability (Institut de Recherche Pierre Fabre, France), co-founder and Associate Editor of mAbs journal (2009) and chairman of MabDesign SAB (2014). He is or was involved in +12 clinical stage biologics R&D programs including dalotuzumab/ ...

Close Full biography

Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre

Jason Beckwith, SVP Talent Science & Thought Leadership | BioTalent, Evolution

×

Julia Behnke, CEO and Co-Founder, ingineeon | advanced immunotherapeutics

Julia has been researching on immune proteins already during her PhD at a leading hospital in the US. Afterwards Julia was involved in development of various therapeutics from preclinics up to clinical and market access strategy development in the industry. After combining this expertise with...

Close Full biography

Julia Behnke, CEO and Co-Founder, ingineeon | advanced immunotherapeutics

Marie-Emmanuelle BEHR-Gross, Scientific Programme Manager, Biological Standardisation Programme, E.D.Q.M. Council Of Europe

×

Nicola Beltraminelli, Chief Development Officer, Head of RED, INNATE PHARMA

Dr. Nicola Beltraminelli joined Innate Pharma as Vice President and Chief Development Officer in January 2022 and was recently appointed as Head of Reasearch Early Development of the organization. Dr. Beltraminelli brings 25 years of biotech experience to the role, and specifically in the...

Close Full biography

Nicola Beltraminelli, Chief Development Officer, Head of RED, INNATE PHARMA

×

Tobias Bergauer, Senior Principl Scientist, Roche

20+ years of experience in R&D, project, and portfolio management in the biotech and pharmaceutical industry, with a focus on genetic and genomic biomarkers, associated assay technologies, and genomic therapeutic modalities. My core competencies include research project, portfolio...

Close Full biography

Tobias Bergauer, Senior Principl Scientist, Roche

×

Andrea Bertaglia, Director, Head of Analytical Operations, Ironwood Pharmaceuticals

Andrea is Director of Analytical Operations at Ironwood Pharmaceuticals, Inc., where he focuses on developing robust analytical strategies aligned with regulatory and compliance expectations for a GLP-2 analogue. He has 13 years of experience in the pharmaceutical industry across biotech and large...

Close Full biography

Andrea Bertaglia, Director, Head of Analytical Operations, Ironwood Pharmaceuticals

Matthieu Besneux, Head of Research, Ennovate

×

Adrian Bloch, PhD, TU Darmstadt

Adrian Bloch is a PhD candidate in the research group of Prof. Harald Kolmar at the Technical University of Darmstadt, Germany. His research focuses on the generation and engineering of antibodies, with a particular emphasis on the development of masking strategies. He aims to establish broadly...

Close Full biography

Adrian Bloch, PhD, TU Darmstadt

Vladimir Bobkov, Principal Scientist, Argenx

×

Sara Bonetti, Senior Scientist, Salipro Biotech AB

Sara Bonetti is Senior Scientist at Salipro Biotech, a company located in Stockholm, Sweden, working on stabilizing challenging drug targets for drug discovery. Prior to joining Salipro Biotech, Sara obtained her PhD in Biochemistry and Molecular Biology from the University of...

Close Full biography

Sara Bonetti, Senior Scientist, Salipro Biotech AB

Louis Boon, Chief Scientific Officer and Board member JJP Biologics, JJP Biologics

Laure Bouchez, Executive in Residence and CSO Ennovate, Worgpharma c/o Innovation Park Basel

×

Frederic Bouder, Professor Of Risk Management, University of Stavanger

Prof. Frederic Bouder has developed policy-oriented research on risk communication and risk regulation, with a strong transatlantic and comparative dimension. His interest for medicines has taken central stage in his career including in the area of vaccines and biotechnology. His research interests ...

Close Full biography

Frederic Bouder, Professor Of Risk Management, University of Stavanger

Caroline Boulliat, CEO & Founder, Genchrome

×

Diego Braguglia, GP, Vi Partners

Diego has more than two decades of venture capital experience and has developed a solid experience in creating, growing and exiting ventures in therapeutics and medical devices. He served as chairman and non-executive director in Endoart (acquired by Allergan), Endosense (acquired by St...

Close Full biography

Diego Braguglia, GP, Vi Partners

Sebastian Breuer, Innovation Lead & Preclinical Project Leader at pRED, Roche Diagnostics GmbH

Bryan Briney, Associate Professor, The Scripps Research Institute

Sascha Oliver Bucher, Co-Founder and Partner, Forty51 Ventures AG

×

Luigi Buonaguro, Lab director, National Cancer Institute

Dr. Luigi Buonaguro is the Director of the Innovative Immunological Models at the National Cancer Institute - IRCCS “Pascale ”, Naples – Italy. He is an expert in identification and characterization of tumor antigens for preventive/therapeutic cancer vaccine development. His focus is mostly on...

Close Full biography

Luigi Buonaguro, Lab director, National Cancer Institute

×

Fanny Burger, PhD student in Biology, University of Strasbourg

Fanny Burger is a PhD candidate in research group of NPI team at the UMR 7199 CBST laboratory, University of Strasbourg, France, under the supervision of Prof. Françoise Pons. Her research focuses on harnessing carbon dot nanoparticles as delivery vectors for siRNA, with the goal of exploring...

Close Full biography

Fanny Burger, PhD student in Biology, University of Strasbourg

Floris Burgering, Global Manufacturing Network Program and Risk manager, Genentech/Roche

×

Nicola Burgess-Brown, Principal Investigator, University College London

Nicola obtained her Ph.D. in Molecular Microbiology at the University of Nottingham, then worked in industry on high-throughput cloning and validation of therapeutic cancer antigens for Oxford Glycosciences and subsequently Celltech R&D. She then spent 17 years at the University of...

Close Full biography

Nicola Burgess-Brown, Principal Investigator, University College London

×

Johannes Buyel, Head of Department, B.O.K.U.

After a B.Sc. in Biotechnology at the RWTH Aachen University (2006), Johannes studied in Sweden and the USA during his masters, which he finished with honors in 2009. He finished his first PhD focusing on recombinant protein expression in plants in 2013, then starting as a group leader for...

Close Full biography

Johannes Buyel, Head of Department, B.O.K.U.

×

Martinus Capelle, Distinguished Scientist II, Janssen

Martinus Capelle is working at Johnson & Johnson Innovative Medicine as Distinguished Scientist II in the global Drug Product Development & Delivery organization. He is an innovative Drug Product leader and CMC strategist with ~25 years of experience across pre‑clinical to late‑stage...

Close Full biography

Martinus Capelle, Distinguished Scientist II, Janssen

Marta Carrasco, Data Governance & Operations Lead, Roche

×

Maurizio Ceppi, CSO, Transgene SA

Maurizio is a biotech executive with over 15 years of experience in oncology drug development and diagnostics, specializing in translational medicine. With deep expertise in cancer immunotherapy, he has contributed to the development of monoclonal and bispecific antibodies, small molecules, and...

Close Full biography

Maurizio Ceppi, CSO, Transgene SA

Prasun Chakraborty, Founder & CEO, Genevation LTD

×

Mark Chiu, President, Tavotek Biotherapeutics

Mark is the Chief Scientific Officer at Tavotek Biotherapeutics.  He has nearly 35 years of experience in new drug discovery for AbbVie/Abbott Laboratories and Janssen. Prior to joining Tavotek, Dr. Chiu was the Head of the Process Analytical Sciences at Biotherapeutics Development and Head of...

Close Full biography

Mark Chiu, President, Tavotek Biotherapeutics

×

Andre Choo, Deputy Executive Director, Bioprocessing Technology Institute

A/Prof Andre Choo obtained his PhD from the University of Technology Sydney focusing on the molecular engineering of antibody fragments and immunotoxins. He was also involved in the characterization of a mAb that induced apoptosis of kappa-myelomas.  This is currently pursued by HaemaLogiX in Phase ...

Close Full biography

Andre Choo, Deputy Executive Director, Bioprocessing Technology Institute

×

Anandi Chowdhury, Ph.D. Candidate, Indian Institute of Technology Delhi

Anandi Chowdhury is a researcher at the Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology Delhi, India. With over seven years of experience in biopharmaceutical research, she specializes in protein aggregation, biologic stability, and the development of...

Close Full biography

Anandi Chowdhury, Ph.D. Candidate, Indian Institute of Technology Delhi

David Church, Professor, Nuffield Department of Health

×

Michaela Cohrs, PhD student, Ghent University

Michaela Cohrs is a PhD candidate at Ghent University under the supervision of Prof. Hristo Svilenov and Prof. Stefaan De Smedt. Her research focuses on the analysis and prevention of antibody aggregation, with projects ranging from early candidate screening to formulation development and...

Close Full biography

Michaela Cohrs, PhD student, Ghent University

Bebeka Cosandey, Lead Scientific Program Manager, University Hospital Basel

×

Silvia Crescioli, Business Intelligence Creator, The Antibody Society

Silvia Crescioli is an independent consultant specializing in business intelligence and science communication for antibody therapeutic research and development. Drawing on her background as an antibody engineer and cancer immunologist, she combines scientific expertise and analytical insight to...

Close Full biography

Silvia Crescioli, Business Intelligence Creator, The Antibody Society

Mehdi Damaghi, Professor- lab head, Stony Brook Hospital

×

Stefan Dätwyler, Single Use Business Development, ASEPTCONN

Stefan Dätwyler brings over 15 years of experience in commercial growth and leadership, with deep expertise in the single-use market, its dynamics, and its technical requirements.

Close

Stefan Dätwyler, Single Use Business Development, ASEPTCONN

Jeroen de Keijzer, Scientific Manager, Janssen

×

Fabienne DECKERT, Founder and Managing Director, COMPLYOMICS Sàrl

Dr Fabienne Deckert is the founder and Managing Director of Complyomics, a company supporting Life Sciences organizations with customized Quality Systems and tailored Bioanalytical solutions with a focus on compliance with regulatory requirements. With 30 years in the international Pharma industry ...

Close Full biography

Fabienne DECKERT, Founder and Managing Director, COMPLYOMICS Sàrl

Laetitia Devy-Dimanche, CEO, ACLRT.Bio

×

Kumar Dhanasekharan, President and CEO, Gokyo Biosciences Inc.

Dr. Kumar Dhanasekharan, is building a CMC-led biologics development company with an initial pipeline of differentiated biosimilars and other biologics. Most recently, he served as the Senior Vice President of Technical Operations at Voyager Therapeutics, where he oversaw multi-modality CMC...

Close Full biography

Kumar Dhanasekharan, President and CEO, Gokyo Biosciences Inc.

×

Victor Manuel Díaz Cortés, Head of Research, OneChain Immunotherapeutics

Dr. Victor M Diaz is Head of Research at OneChain Immunotherapeutics, where he leads the development of advanced cell and gene therapies with a strong translational and industrial focus. He holds a PhD in Biochemistry from the University of Barcelona and trained as a Marie Skłodowska-Curie...

Close Full biography

Victor Manuel Díaz Cortés, Head of Research, OneChain Immunotherapeutics

Susanne Diehl, Global Program Head, Novartis Pharma AG

Michaela Dinboeck, Head Patient Engagement, Novartis

Tom Dixon, Senior Structural Computational Biologist, Etcembly Ltd

Harsha Doddihal, Global Clinical Lead, Tellix

×

Ebenezer Doku, Regulatory Affairs Lead, Roche products Ghana Ltd.

Ebenezer Doku is a Regulatory Affairs Professional with over 12 years of expertise spanning pharmaceutical manufacturing quality systems and global regulatory strategy. Specializing in emerging markets, he focuses on lifecycle management, dossier optimization, and health authority...

Close Full biography

Ebenezer Doku, Regulatory Affairs Lead, Roche products Ghana Ltd.

×

Marco Dominietto, Chief Technology Officer, AIGON Health

Marco Dominietto, PhD, is a medical physicist and AI researcher working at the intersection of physics, medicine, and artificial intelligence. He has over 20 years of experience in medical imaging, computational modeling, and multimodal data integration, with a focus on developing...

Close Full biography

Marco Dominietto, Chief Technology Officer, AIGON Health

×

Hugo Dorison, Researcher, CEA

Hugo Dorison defended his PhD in DNA repair specifically on uncovering novel regulation modalities of nucleases in the yeast model. After a postdoc focused on OMICs and bioinformatics on patient derived primary cells, Hugo took a junior researcher position in the CEA to perform Monoclonal Antibody...

Close Full biography

Hugo Dorison, Researcher, CEA

Zorica Dragic, Executive Director Cell Line Screening and Development, Novartis International AG

Cyrille Dreyfus, Associate Director, Head of Protein Science, Ichnos Glenmark Innovation

Nadjia Drici, Global Head of IT Clinical and Development Strategy, Biogen

×

Stefan Dübel, Director, Technical University of Braunschweig

Stefan Dübel is Full Professor of Biotechnology and Director of the corresponding department at the Technical University of Braunschweig, Germany. After completing his PhD at the University of Heidelberg, he joined the German Cancer Research Center (DKFZ) in 1989, where he pioneered in vitro...

Close Full biography

Stefan Dübel, Director, Technical University of Braunschweig

Michael Dyson, Vice President - Antibody Discovery & Engineering, Ichnos Glenmark Innovation

Lasse Ebdrup Pedersen, Associate Professor, Technical University of Denmark

Nora Eifler, Head Drug Substance Project Management, Novartis

Géraldine Eudier, Section Head, Biologics Formulation and Process Development, Sanofi

×

Séverine Fagète, Vice President, Mammalian Cell Line Services, KBI Biopharma

Séverine is the Vice President of Mammalian Cell Line Development (CLD) at KBI Biopharma’s Geneva Facility. Prior to the operational consolidation with KBI, Séverine held multiple leadership roles with escalating responsibilities at Selexis. She brings nearly two decades of experience in the...

Close Full biography

Séverine Fagète, Vice President, Mammalian Cell Line Services, KBI Biopharma

×

Matthias Feige, , Technical University Munich

Prof. Feige (*1979) pursues an interdisciplinary approach to address fundamental questions in cellular protein biochemistry: how do cells control that the proteins they produce are correctly structured? How is it ensured that defective proteins are recognized and degraded instead of having...

Close Full biography

Matthias Feige, Technical University Munich

×

Nadia Fernandez, Industry Clinical Collaboration Leader, F. Hoffmann-La Roche Ltd.

I have more than 20 years of experience in the pharmaceutical industry and have held various positions in clinical trial management, procurement and medical affairs. As an Industry Clinical Collaboration Leader, I focus on bringing new and innovative treatment combinations to patients through...

Close Full biography

Nadia Fernandez, Industry Clinical Collaboration Leader, F. Hoffmann-La Roche Ltd.

Hector Marcelo Fernandez Lahore, Associate Professor, Luxembourg Institute of Science and Technology

Pierre Ferré, Chief Operating Officer, Compugen Ltd

Dan Foxler, Head of Cell Biology, LabGenius Tx

×

Tim Fugmann, CSO and Co-founder, Alithea Bio

Tim Fugmann, CSO and Co-Founder of Alithea Biotechnology, holds a PhD from ETH Zurich and was 10 years in biotech industry in Switzerland before being appointed Prof. for mass spectrometry-based proteomics in Giessen, Germany. For many years, he is studying HLA-presented peptides in health and...

Close Full biography

Tim Fugmann, CSO and Co-founder, Alithea Bio

Norbert Furtmann, Head of Computational and High-Throughput Protein Engineering, SANOFI

×

Sreekanth Gattu, Global Program Head, Sandoz

Global Program Head at Sandoz Biopharmaceuticals, Basel, Switzerland; overseeing end to end development of biosimilars starting from early R&D, clinical development through commercialization. A physician by training and has about 15 years of experience in clinical development covering...

Close Full biography

Sreekanth Gattu, Global Program Head, Sandoz

Krist Gernaey, Professor, Chemical & Biochemical Engineering, Technical University of Denmark

Felix Geyer, PhD student, TU Darmstadt

Virginia Ghizzani, PhD, University of Pavia

×

Ettore Gilardoni, Head of Mass Spectrometry, Philochem

Ettore Gilardoni is Head of Mass Spectrometry at Philochem AG. The team main activities vary from biodistribution of small organic molecules in biospecimens; biopharmaceuticals characterization, and proteomics application for target identification; host cell proteins characterization, and mechanism ...

Close Full biography

Ettore Gilardoni, Head of Mass Spectrometry, Philochem

Arnaud Goepfert, Executive in Residence, Ennovate Pharma

×

Steffen Goletz, Professor, Department of Biotechnology and Biomedicine, Danish Technical University

PhD, Professor, Head of RG Biotherapeutic Glycoengineering & Immunology, DTU Bioengineering, Technical University of Denmark. Focus on novel bi- and multispecific antibody and cell-based therapeutics in immunooncology and infectious diseases. After early career in academic research, e.g. MDC in ...

Close Full biography

Steffen Goletz, Professor, Department of Biotechnology and Biomedicine, Danish Technical University

×

A. Pedro Gonçalves, Principal scientist, VTT Technical Research Centre of Finland

I am a Principal Scientist in the Industrial Biotechnology and Food research division at VTT - Technical Research Centre of Finland. Our Protein Production team excels in fungal strain engineering and high-yield production of enzymes as well as food, material, and pharmaceutical proteins.

Close

A. Pedro Gonçalves, Principal scientist, VTT Technical Research Centre of Finland

Iris Good, Chairman, Good Relations India LTD

Francisca Gouveia, Innovation, Data and Digital & Validation Lead, Novartis

×

Torbjorn Graslund, prof., KTH Royal Institute of Technology

Professor Torbjörn Gräslund holds a Ph.D. in Biotechnology from KTH - Royal Institute of Technology, Sweden, since 2001. Following two years of post-doctoral training with Professor Carlos Barbas at the Scripps Research Institute, he has been a principal investigator at the Department of Protein...

Close Full biography

Torbjorn Graslund, prof., KTH Royal Institute of Technology

Philip Grossen, Principal Scientist, Roche

Uwe Gudat, CMO, Biocon Biologics

×

Ivan Gudelj, Assistant Professor, University of Zagreb, Faculty of Pharmacy and Biochemistry

Ivan Gudelj is an Assistant Professor at the University of Zagreb, Faculty of Pharmacy and Biochemistry, specializing in glycoscience and antibody biology. His research focuses on IgG glycosylation and its role in immune regulation and disease. He has authored over 40 peer-reviewed publications and ...

Close Full biography

Ivan Gudelj, Assistant Professor, University of Zagreb, Faculty of Pharmacy and Biochemistry

Michael Gutknecht, Principal Scientist II, Novartis Pharma AG

×

Supriyadi Hafiz, Senior Scientist – Excipients R&D, Merck KGaA

Supriyadi Hafiz is a Senior Scientist Formulation and Technical Project Lead in Excipients R&D, based in Darmstadt, Germany. He holds an M.S. in Biosystem Technology from Darmstadt University of Applied Sciences, Germany. With over 13 years at the company, he has held various roles within Life...

Close Full biography

Supriyadi Hafiz, Senior Scientist – Excipients R&D, Merck KGaA

Charlotte Hagman, Team lead, Novartis

Isaac Haq, Managing Partner, HINA Bioventures

×

Anissa Harbi, Immunologist, Les Hôpitaux d'Alger

Anissa Harbi is an Immunologist MD from Annaba, Algeria, with a strong background in clinical research and patient care. Currently serving as an Immunologist at Les Hôpitaux d'Alger, Anissa is dedicated to advancing medical knowledge and improving patient outcomes.

Close

Anissa Harbi, Immunologist, Les Hôpitaux d'Alger

Julian Harrison, Postdoctoral Researcher, ETH Zürich,

×

Julia Harwardt, Scientist, Merck Healthcare KGaA

Julia Harwardt is a Bench Scientist in the Antibody Discovery & Protein Engineering department at Merck KGaA. She joined the company after completing her PhD in the group of Prof. Dr. Harald Kolmar at the Technical University of Darmstadt. With a strong background in biochemistry and antibody...

Close Full biography

Julia Harwardt, Scientist, Merck Healthcare KGaA

×

Hooman Hefzi, Associate Professor, Danish Technical University

Hooman is currently an Associate Professor at the Technical University of Denmark where his research group broadly aims to engineer mammalian cells for improved cellular behavior in fields including biologics manufacturing and cultivated meat. He previously led the Omics and Modeling Team in...

Close Full biography

Hooman Hefzi, Associate Professor, Danish Technical University

×

Fabian Higel, Global NBE CME Expert, Boehringer Ingelheim

Dr. Fabian Higel is a Global CMC Expert at Boehringer Ingelheim with more than ten years of experience in the development of biological drug products across the full lifecycle, from early discovery to market entry. He has held leadership roles across multiple functions within the biopharmaceutical...

Close Full biography

Fabian Higel, Global NBE CME Expert, Boehringer Ingelheim

×

Oliver Hill, Senior Director Protein Engineering, Yumab GmbH

Oliver Hill is an experienced biotechnology professional specializing in protein engineering and drug discovery. Currently, he serves as Senior Director of Protein Engineering at YUMAB GmbH, focusing on advancing antibody-based therapeutics for clients. Oliver has held leadership roles at TriCos...

Close Full biography

Oliver Hill, Senior Director Protein Engineering, Yumab GmbH

×

Sebastian Hörner, Senior Scientist, BiconY Therapeutics

Sebastian Hörner joined BiconY Therapeutics as a Senior Scientist in 2023. He studied technical biology at the University of Stuttgart from 2011 to 2017, where he started his work in the field of recombinant antibodies in the lab of Roland Kontermann. From 2017 to 2021, he worked as a PhD candidate ...

Close Full biography

Sebastian Hörner, Senior Scientist, BiconY Therapeutics

Steven Howe, VP Process Development, Resolution Therapeutics Ltd

×

Sherlock Hu, CIO, GV20 Therapeutics

Dr. Xihao “Sherlock” Hu is Chief Information Officer and a founding member of GV20 Therapeutics, a biotech company that uses AI to design novel antibody drugs. He holds a Ph.D. in Computer Science from the Chinese University of Hong Kong and completed postdoctoral training at Dana-Farber Cancer...

Close Full biography

Sherlock Hu, CIO, GV20 Therapeutics

Michael Huebner, Director, Country Lead EIP, Johnson & Johnson Innovation

×

Martin Huelsmeyer, Senior Principal Research Scientist, AbbVie

Martin Huelsmeyer is chemist by training and received his PhD in Structural Biology from Technical University Braunschweig, Germany. Prior joining Abbvie in 2012, he held positions in academia at University of Würzburg, Technical University Berlin, University Hospital Charité Berlin and was...

Close Full biography

Martin Huelsmeyer, Senior Principal Research Scientist, AbbVie

×

Mariana Hugo Borges Barreto Silva, Postdoctoral Fellow, University of Ghent

Mariana Hugo Silva is a Postdoctoral Researcher at Ghent University, working closely with Pfizer to provide mechanistic insights into mRNA-LNP vaccines. She earned her PhD from the University of Limerick, Ireland, conducting research across academic and industry settings including Johnson &...

Close Full biography

Mariana Hugo Borges Barreto Silva, Postdoctoral Fellow, University of Ghent

×

Melita Irving, Group Leader, University of lausanne

Originally from Canada, Dr. Melita Irving began working in the field of T-cell engineering for cancer immunotherapy in Switzerland in 2007. She has been a group leader at the Ludwig Institute for Cancer Research in the Department of Oncology at the University of Lausanne for the past 12...

Close Full biography

Melita Irving, Group Leader, University of lausanne

Barbara Jackova, Post-doctoral researcher in Biotechnology, Sanofi

Ruediger Jankowsky, CEO, AATec Medical GmbH

×

Hans Johansson, General Manager, Sunresin

Hans J Johansson is General Manager for Sunresin Sweden based in Uppsala, Sweden. He has spent more than 35 years in the Biotech industry. Most of the time in research and development at Pharmacia (now Cytiva), and Purolite (now Ecolab) with a special focus on design and applications of industrial...

Close Full biography

Hans Johansson, General Manager, Sunresin

×

Colette Johnston, VP - Head of Product Platform Research, Enara Bio

Colette has been Head of Product Pipeline at EnaraBio since 2023, building bispecific T cell engagers that recognise novel cancer targets. She has more than 15 years experience in the biopharmaceutical industry, with a strong focus on antibody discovery, transgenic platforms, protein engineering...

Close Full biography

Colette Johnston, VP - Head of Product Platform Research, Enara Bio

×

Peter Jorgensen, Chief Executive Officer, Danish Generic and Biosimilar Medicines Industry Association (IGL)

Master in Political Science from the University of Copenhagen45+ years of professional experience, including:Head of section in the Ministries of Social Affairs and of LabourLabour Counsellor at the Danish UN-mission in GenevaHealth Counsellor at the Danish EU-representation in BrusselsSpokesman in ...

Close Full biography

Peter Jorgensen, Chief Executive Officer, Danish Generic and Biosimilar Medicines Industry Association (IGL)

×

Alois Jungbauer, Professor, B.O.K.U.

Alois Jungbauer holds a doctorate in food technology and biotechnology from BOKU. He is retired Professor Emeritus of Downstream Processing at the Institute of Bioprocess Science and Technology at BOKU University, Adjunct Professor at University of Adelaide and an active scientist at the Austrian...

Close Full biography

Alois Jungbauer, Professor, B.O.K.U.

Anastasios Karadimitris, Professor, Langmuir Chair in Haematology and Consultant Haematologist, Imperial College London

×

Sophia N Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, King's College London

Translational B cell and cancer immunologist with academic and biotechnology experience in the UK and USA. She heads a cancer antibody discovery team focusing on dissecting the crosstalk between human immunity and solid tumours and understanding the impact of antibody isotype on therapeutic...

Close Full biography

Sophia N Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, King's College London

×

Sebastian Katz, Chief Strategy Officer, SteinCares

Sebastian Katz brings over 20 years of experience in the global pharmaceutical industry across General Management, Finance, Corporate Strategy, and Business Development.As Chief Strategy Officer at SteinCares, Sebastian leads the global business development team and drives the company's...

Close Full biography

Sebastian Katz, Chief Strategy Officer, SteinCares

×

Ian Kerr, Field Specialist II, Ecolab

Ian has over 10 years of experience in downstream processing, with expertise spanning process development in a startup environment, customer‑facing project leadership within CDMOs, and development and GMP operations in large pharmaceutical companies. He particularly enjoys working with...

Close Full biography

Ian Kerr, Field Specialist II, Ecolab

Thomas Klünemann, Director of New Technologies and Antibody Engineering, Yumab GmbH

Nina Kotsopoulou, CTO, AAVantgarde Bio

Kasia Kozakowska-McDonnell, Associate Director, Analytical CMC Lead, AstraZeneca

×

Emanuel Kreidl, Senior Expert, Principal Scientist, Novartis

Emanuel Kreidl is a seasoned Senior Expert and Principal Scientist at Novartis, with a strong background in biologics research and development. With over 15 years of experience in the pharmaceutical industry, Emanuel has made significant contributions to the field of biologics, particularly in the...

Close Full biography

Emanuel Kreidl, Senior Expert, Principal Scientist, Novartis

×

Anil Kumar, Business Development Manager, Kactus

Anil Kumar holds a Ph.D. in Protein Engineering from NTU, Singapore, and brings over a decade of experience in biopharmaceutical R&D, with expertise in protein design and therapeutic innovation for immune-oncology and autoimmune indications.Prior to joining KACTUS Bio, Anil served as Director...

Close Full biography

Anil Kumar, Business Development Manager, Kactus

×

Jon Amund Kyte, Head of Department for Clinical Cancer Research, University of Oslo, Oslo University Hospital

Jon A Kyte has combined expertise as clinical oncologist and immunotherapy researcher and is Head of the Department for Clinical Cancer Research, Oslo University Hospital (OUS), and Professor at Faculty of Medicine University of Oslo (UiO). Kyte is also Research Group Leader at Department Cancer...

Close Full biography

Jon Amund Kyte, Head of Department for Clinical Cancer Research, University of Oslo, Oslo University Hospital

×

Bernd Liedert, Founder / Consultant, BL Consulting

Bernd is a seasoned executive with a history of 25+ years’ experience as leader in academia (West German Cancer Centre, University of Essen Medical School), in regulatory agencies (Paul-Ehrlich-Institute / European Medicines Agency) and in pharmaceutical industry (Merck, Boehringer...

Close Full biography

Bernd Liedert, Founder / Consultant, BL Consulting

×

Alfred Lim, Director of Lab Research, Etcembly Ltd

Alfred is Director of Lab Research at Etcembly, where he leads the development of new TCR drug candidates from discovery through to preclinical characterization and translational development. He was previously Head of Discovery at Theolytics and was responsible for candidate optimisation and lead...

Close Full biography

Alfred Lim, Director of Lab Research, Etcembly Ltd

Alessandro Linciano, Site MS & T Head & Technology Lead, Cell and Gene Therapies, Novartis

×

Britta Lipinski, PhD Student, Merck Healthcare KGaA

Britta Lipinski is a PhD candidate in the Antibody Discovery and Protein Engineering Department of Merck KGaA, supervised by Stefan Zielonka, where she works in close collaboration with the group of Prof. Dr. Harald Kolmar at the Technical University of Darmstadt. Her research focuses on the...

Close Full biography

Britta Lipinski, PhD Student, Merck Healthcare KGaA

Lara Lorthiois, Senior Transformation Leader – Operational Excellence & Pharma, Independent

×

Christian Lotz, General Manager EMEA, Pfanstiehl GmbH

Christian Lotz studied Physical Chemistry at the University of Bochum Germany and did his doctorate in Physical Chemistry at the University of Essen in Germany. He started his Industry career at Lipoid GmbH, a GMP manufacturer of parenteral grade phospholipids, in the sales department with...

Close Full biography

Christian Lotz, General Manager EMEA, Pfanstiehl GmbH

×

Robin Löving, CSO, Salipro Biotech AB

Robin Löving, Chief Scientific Officer (CSO) at Salipro Biotech. Robin has more than 15 years’ experience working with therapeutically interesting membrane proteins. He did his PhD with a focus on membrane proteins and antigen design at the Karolinska Institute in Stockholm, Sweden. After being...

Close Full biography

Robin Löving, CSO, Salipro Biotech AB

Declan Lowney, Director of Stability Sciences, BioTherapeutics Development Analytical Development, Johnson & Johnson Innovation

×

Heinz Lubenau, Chief Executive Officer, NEC Bio

Heinz Lubenau is currently Chief Executive Officer and co-founder of NEC Bio Therapeutics where he is leading the AI-empowered personalized neoantigen drug development which includes the proprietary product NECVAX-NEO1 and the clinical collaboration with Transgene’s MyVac product. He has been...

Close Full biography

Heinz Lubenau, Chief Executive Officer, NEC Bio

Francesca Luciani, Senior Researcher, Instituto Superiore di Sanita

×

Rosita Lupi, ADC Platform Head, Nerviano Medical Sciences Srl

Rosita Lupi, PhD, MBA is Head of the ADC Portfolio at Nerviano Medical Sciences, where she leads the development of an innovative Antibody Drug Conjugate platform in oncology. With over 20 years of experience in drug discovery and preclinical development, she has contributed to the advancement of...

Close Full biography

Rosita Lupi, ADC Platform Head, Nerviano Medical Sciences Srl

×

Matthias Machacek, Managing Director, LYO-X AG

Matthias Machacek holds an engineering MS/PhD from ETH Zurich and completed his postdoctoral research in Cell Biology at The Scripps Research Institute. He brings more than 30 years of experience in modeling and simulation, supporting the preclinical and clinical development of biologics and other...

Close Full biography

Matthias Machacek, Managing Director, LYO-X AG

×

Bernard Maillere, Head of laboratory, CEA

Bernard Maillere is head of the Laboratory of Cellular Immunology and Biotechnology of the CEA, a French governmental research institute. He  is also head of the immunology section of the doctoral school "therapeutic innovation" of the University of Paris-Saclay. He holds a Master's...

Close Full biography

Bernard Maillere, Head of laboratory, CEA

×

Alessio Maiolica, Director, Novartis

Alessio Maiolica is a bioanalytical leader at Novartis, focused on shaping bioanalytical strategy and operating models that enable reliable decision-making across drug development. He works at the intersection of governance, portfolio execution, and laboratory innovation to deliver fit-for-purpose...

Close Full biography

Alessio Maiolica, Director, Novartis

×

Nirmal Mallick, Student, IIT Delhi

I, Nirmal Mallick, is currently pursuing research at Indian Institute of Technology, Delhi in the area of Bioreactor Design and process optimization under the guidance of Prof. Anurag S. Rathore. During this research I worked with the geometry of different size of reactor starting from 0.6 ltr to...

Close Full biography

Nirmal Mallick, Student, IIT Delhi

×

Salah Mansour, Associate Professor in Cellular Immunology, University of Southampton

Dr Salah Mansour is an Associate Professor at the University of Southampton. His research focuses on unconventional T cells, particularly CD1-restricted and invariant natural killer T (iNKT) cells, and their application in cancer immunotherapy and infectious disease. His work combines structural...

Close Full biography

Salah Mansour, Associate Professor in Cellular Immunology, University of Southampton

×

Julie Maréchal-Jamil, Executive Director, Medicines for Europe

Julie Maréchal-Jamil is a seasoned professional with over 15 years of experience in the pharmaceutical industry. Currently serving as the Senior Director of Pharmaceutical Policy at Medicines for Europe, she is a respected expert in the field of biologics and healthcare policy. Julie's...

Close Full biography

Julie Maréchal-Jamil, Executive Director, Medicines for Europe

Johanna Marines, Head of Preclinical, Mabqi

Wyatt McDonnell, CEO, Infinimmune

×

Duccio Medini, Chief Technology and Science Officer, Pitt BioForge

Duccio Medini is a scientist and pharmaceutical executive currently serving as Chief Science and Technology Officer at Pitt BioForge (Pittsburgh, PA) and as Strategic Data Science Director at Toscana Life Sciences Foundation (Siena, Italy)He designed and led the Wellcome Leap $60M "R3: RNA...

Close Full biography

Duccio Medini, Chief Technology and Science Officer, Pitt BioForge

Shirley Mei, Investigator, Ottawa Hospital Research Institute

Paula Meleady, Associate Professor, Dublin City University

Nicolas Melin, CEO of AquiLiv, AquiLiv

×

Virginia Metrangolo, Postdoc/Co-founder CSO PanTarg, University of Copenhagen

Virginia Metrangolo is a Medical biotechnologist working as a postdoctoral researcher in the Engelholm research group at the Finsen Laboratory/Biotech Research and Innovation Centre in Copenhagen. Her research work involves the development of antibody-based therapies, mostly antibody-drug...

Close Full biography

Virginia Metrangolo, Postdoc/Co-founder CSO PanTarg, University of Copenhagen

×

Lydia Michaut, Director scientific governance PK sciences, Novartis

Lydia is currently Director of Bioanalytical Governance for Biologics and Novel Therapies at Novartis PK Sciences, in Basel She has over 15 years of expertise in biotherapeutics and gene therapies development in large pharma, CROs, and consultancy, and is is a member of the European Immunogenicity ...

Close Full biography

Lydia Michaut, Director scientific governance PK sciences, Novartis

×

Enkelejda Miho, Professor Of Digital Life Science Sciences, University of Applied Sciences Northwestern Switzerland

Enkelejda Miho is Professor of Digital Life Sciences at the FHNW University of Applied Sciences and Arts Northwestern Switzerland. She is head of the Laboratory of Artificial Intelligence in Health (www.aihealth.ch). Her research is focused in the application of artificial intelligence to health...

Close Full biography

Enkelejda Miho, Professor Of Digital Life Science Sciences, University of Applied Sciences Northwestern Switzerland

×

Anika Mijakovac, Expert associate/Senior researcher, Faculty of Science, University of Zagreb

Dr. Anika Mijakovac is an expert associate at the Faculty of Science, University of Zagreb and a senior researcher in Genos working in the field of epigenetics and protein glycobiology. Her primary focus is immunoglobulin G (IgG) glycosylation in aging and disease. In her research she uses...

Close Full biography

Anika Mijakovac, Expert associate/Senior researcher, Faculty of Science, University of Zagreb

×

DR Michel Mikhail, Expert in Global Regulatory Affairs and Governmental relations, Expert in Biosimilars, Independent

Dr. Michel Mikhail has more than 30 years Pharmaceutical Industry experience and track record of achievement in R & D and International Regulatory Affairs in large multinational Research-based pharmaceutical Companies as well as Generic & Biosimilars companies. He also has global experience ...

Close Full biography

DR Michel Mikhail, Expert in Global Regulatory Affairs and Governmental relations, Expert in Biosimilars, Independent

Élodie Miranda, SVP General Manager International Markets, Iovance Biotherapeutics

Maria Mitsi, Senior Scientist, University Hospital Zurich

×

Ravishankara MN, Senior General Manager, Analytics- Function Head, Sun Pharma

Ravishankara MN currently hold the position of Senior General Manager at Sun Pharmaceutical Industries Limited and leading Team involved in Analytical activities related to development of Biologics and Peptides. He is having about 23 years of experience and his research interest includes Critical...

Close Full biography

Ravishankara MN, Senior General Manager, Analytics- Function Head, Sun Pharma

×

Lorenzo Montrasio, Secretary General, VolRethics

Since 2024, Lorenzo has worked as an independent advisor, collaborating with national governments and international organizations to promote partnerships for medicine development and strengthen regulatory systems. Previously, he led the work on access to innovative treatments and technologies at...

Close Full biography

Lorenzo Montrasio, Secretary General, VolRethics

Caroline Morris, Senior Scientist – Peptide Chemistry, AstraZeneca

×

Ejvind Mørtz, Chief Scientific Officer and Co-Founder, Alphalyse

Ejvind Mørtz is a leading figure in proteomics and mass spectrometry analysis with more than 30 years of experience in biotechnology and protein biologics development. He holds a PhD in Protein Chemistry and Molecular Biology from the University of Southern Denmark. He has specialized in developing ...

Close Full biography

Ejvind Mørtz, Chief Scientific Officer and Co-Founder, Alphalyse

×

Guillaume Mottet, Lab Head, sanofi

After completing his Ph.D. studies in 2009 in microfluidic chip field, he continued as postdoctoral fellow at Institut Curie in the team of Jean Louis Viovy and developed thermoplastic chips for diagnostics. In 2013, he went on to apply droplet microfluidics for the study of molecular evolution in...

Close Full biography

Guillaume Mottet, Lab Head, sanofi

Michael Muenzberg, CEO, Targeted Soloutions

Michael Mullin, Head of Antibody Engineering, LabGenius Therapeutics

×

Christian Neusüß, Professor Analytical Chemistry, Hochschule Aalen

Christian Neusüß is Professor for Instrumental Analytical Chemistry with focus on Mass Spectrometry at Aalen University. He received his diploma from University of Heidelberg and his PhD from University of Leipzig. His research interests include coupling and application of (electromigrative)...

Close Full biography

Christian Neusüß, Professor Analytical Chemistry, Hochschule Aalen

Sarfaraz Niazi, CEO, Karyo Biologics, LLC

×

Cecil Nick, Vice President (Technical), Parexel

Cecil Nick, Vice President (Technical), at PAREXEL has been working in regulatory affairs and clinical development for over 40 years; mosly focused on biological medicines. Cecil Nick has particular expertise in vaccines, monoclonals and biosimilars, and has engaged in over 100 interactions and...

Close Full biography

Cecil Nick, Vice President (Technical), Parexel

×

Björn Niebel, Senior Principal Scientist, Sanofi Ghent - Sanofi R&D

Björn Niebel is a Senior Principal Scientist, Group Head in the Discovery Department of the Nanobody Research Platform at Sanofi Ghent. Björn received his master’s degree in Chemistry from the University of Braunschweig, Germany in 2006 and holds a PhD in Biochemistry from the University of...

Close Full biography

Björn Niebel, Senior Principal Scientist, Sanofi Ghent - Sanofi R&D

Haneen Njoum, Senior Data Scientist, sanofi

Jonathan Novak, SVP & Global Head Technical R&D Biologics and Cell & Gene Therapy, Novartis

×

Olga Obrezanova, AI Principal Scientist, AstraZeneca

Dr. Olga Obrezanova is an AI Principal Scientist in the Augmented Biologics Design group at Biologics Engineering, AstraZeneca, based in Cambridge, UK. With 20 years of experience, Olga specializes in applying machine learning & artificial intelligence and developing computational tools for...

Close Full biography

Olga Obrezanova, AI Principal Scientist, AstraZeneca

David O'Connell, Associate Professor, School Of Biomolecular And Biomedical Science, University College Dublin

×

David Öling, Director - Molecular Biology and Recombinant Protein Production, AstraZeneca

David is a director at the department for Protein Science, Structure and Biophysics – Discovery Science – AstraZeneca. Before joining AstraZeneca, he completed his PhD at University of Gothenburg working on protein quality control pathways controlling cellular aging and rejuvenation. He joined...

Close Full biography

David Öling, Director - Molecular Biology and Recombinant Protein Production, AstraZeneca

Ayman Oweida, Associate Professor, Canada Research Chair, Université de Sherbrooke

Roland Pach, Global Expert Cell & Gene Therapy Analytics CMC, F Hoffmann-La Roche

Shaloo Pandhi, Chief Medical Officer, Senior Vice President, Global Head, Patient Safety, Sandoz

×

Arijit Patra, Senior Principal Scientist, UCB

Dr Arijit Patra is a Senior Principal Scientist at UCB UK and a Honorary Senior Lecturer (Associate Professor) at the University of Glasgow. He holds a PhD in machine learning for healthcare imaging from the University of Oxford, where he was a Rhodes Scholar (India & Exeter, 2016). Prior to...

Close Full biography

Arijit Patra, Senior Principal Scientist, UCB

Vijaya Pattabiraman, Co-founder & CTO, Bright Peak Therapeutics

Sofie Pattyn, Board Member, European Immunogenicity Platform

×

Matthias Peipp, Head - Division of Antibody-Based Immunotherapy, UKSH - University Hospital Schleswig-Holstein

Matthias received his PhD at the chair of genetics at the Friedrich-Alexander-University (Erlangen- Nuremberg, Germany). In 2015 he was awarded an endowed professorship, the “Mildred-Scheel-Professorship for Experimental Antibody-Based Cancer Immunotherapy”. Matthias has a long-standing expertise...

Close Full biography

Matthias Peipp, Head - Division of Antibody-Based Immunotherapy, UKSH - University Hospital Schleswig-Holstein

Catherine Pemberton-Ross, Principal Scientist II, Novartis

×

Kalyani Pemmaraju, Director - Operations (Formulation, Fill/Finish and Packaging), External Supply and Manufacturing, AstraZeneca

Kalyani is a biopharmaceutical professional with 30 years of experience in various aspects of biologics, such as CMC development, CMC regulatory, large-scale manufacturing, launch and commercialization.  She worked across multiple therapeutic areas...

Close Full biography

Kalyani Pemmaraju, Director - Operations (Formulation, Fill/Finish and Packaging), External Supply and Manufacturing, AstraZeneca

×

Isabelle Petit-Topin, Team/Lab Lead in Downstream Process _ Manufacturing Science and Technology (DSP MS and T), Novartis France

Isabelle Petit Topin is a passionate professional for Protein biochemistry and all that has to do with protein in general. Graduated at the University Paris Diderot, Isabelle obtained her PhD in 2009 (CIFRE HRA Pharma - Inserm - Paris) in Protein Biochemistry and Crystallography. After her...

Close Full biography

Isabelle Petit-Topin, Team/Lab Lead in Downstream Process _ Manufacturing Science and Technology (DSP MS and T), Novartis France

Maria Pihlgren Bosch, Senior Director, Ichnos Glenmark Innovation, IGI

×

Sebastian Pirner, Scientist, Roche Diagnostics GmbH

Sebastian Pirner is a dedicated scientist with a passion for driving innovation in the field of biologics. With a strong background in biochemistry and mass spectrometry, Sebastian has made significant contributions to the development of novel therapeutics. His expertise lies in the discovery and...

Close Full biography

Sebastian Pirner, Scientist, Roche Diagnostics GmbH

×

Andreas Plueckthun, Professor, University of Zurich

Andreas Plueckthun is a distinguished Professor of Biochemistry and the Director of the Department of Biochemistry at the University of Zurich. With a strong background in protein engineering and molecular biology, he is a renowned expert in the field of biologics. Dr. Plueckthun's research...

Close Full biography

Andreas Plueckthun, Professor, University of Zurich

×

Simon Plyte, CSO, Biomunex Pharmaceuticals

Dr Plyte has over 25 years of experience in drug development both in Big Pharma and Small Biotech predominantly applied to Oncology and immuno-Oncology. Over the last 15 years he has focussed on the development of biologics with an emphasis of multi-specific antibody formats having differing drug...

Close Full biography

Simon Plyte, CSO, Biomunex Pharmaceuticals

Carolina Pola, CEO, Stab Therapeutics

×

Philipp Probst, Director ADC Research, Araris Biotech AG

Philipp Probst is Director of ADC Research at Araris Biotech AG, a Swiss biotech company located in Au ZH pioneering a novel linker technology for antibody-drug conjugates. He studied Pharmaceutical Sciences and received his PhD from ETH Zürich in 2018, where he worked in the group of Prof. Dario...

Close Full biography

Philipp Probst, Director ADC Research, Araris Biotech AG

×

Emanuele Puca, Chief Operating Officer, Philochem

Chief Operating Officer of the Philogen Group and Board Member of Philochem AG (Philogen discovery center). Graduated in Medicinal Chemistry at La Sapienza University and performed Ph.D. studies at ETH Zürich focusing on the generation of antibody-cytokine fusion proteins for the treatment of...

Close Full biography

Emanuele Puca, Chief Operating Officer, Philochem

Narasimha Pullaguri, Scientist, Hetero Biopharma Limited

Steven Quayle, Senior Vice President & Head of Research and Translational Medicine, Cue Biopharma

×

Moutih Rafei, Full Professor, University of Montreal

Dr. Rafei is an immunologist by training focused on the development of therapies within the immuno-oncology space. Throughout the past decade, he accumulated profound knowledge and insight in the fields of T-cell development, stem cell biology, cancer immunotherapy and autoimmune diseases. While...

Close Full biography

Moutih Rafei, Full Professor, University of Montreal

Monica Raimo, Director of Product and Process Development, Glycostem Therapeutics

×

Tobias Rainer, Senior Associate Scientist, Roche Diagnostics GmbH

Tobias is a mass spectrometrist at Roche Pharma Development in Germany. Coming from the Italian alps, he studied chemistry in Austria and Scotland. Among other responsibilities, his work focuses on advancing the in-depth characterization of novel biopharmaceuticals. Being a passionate...

Close Full biography

Tobias Rainer, Senior Associate Scientist, Roche Diagnostics GmbH

×

Julia Rakovets, Business Manager for Research, NIBRT

Julia Rakovets is the Business Manager for Research at the National Institute for Bioprocessing Research and Training (NIBRT - Ireland), a global center of excellence headquartered in Dublin. Julia specialises in aligning cutting-edge academic research with industrial application. With a career...

Close Full biography

Julia Rakovets, Business Manager for Research, NIBRT

×

Roshan Ramanathan, Founder and Executive Director, Bridges Initiative for Vaccine Regulatory Science and Practice

Dr. Roshan Ramanathan is a physician–scientist specializing in vaccine and biologics development. Her career spans leadership roles at the National Institutes of Health, the U.S. Food and Drug Administration, and the biopharmaceutical industry. As Branch Chief at FDA’s Center for Biologics...

Close Full biography

Roshan Ramanathan, Founder and Executive Director, Bridges Initiative for Vaccine Regulatory Science and Practice

Farshad Ramazani, Functional lead, Novartis

×

Sudarshan Reddy, CEO, Oncosimis Biotech Pvt Ltd

Dr. Reddy is the Founder & CEO of Oncosimis Biotech Pvt. Ltd., and an accomplished leader in drug discovery and innovation in the fields of metabolic and neuromuscular diseases. Under Dr. Reddy’s leadership, Oncosimis Biotech has achieved several notable milestones, including securing 30...

Close Full biography

Sudarshan Reddy, CEO, Oncosimis Biotech Pvt Ltd

Isabell Remus, Global Head of Biosimilars, Sandoz

Mourad Rezk, Independent Global Biotech and Biosimilars Executive, Independent

×

Guilhem Richard, CTO, EpiVax Therapeutics

Guilhem Richard is the Chief Technology Officer of EpiVax. He has over 15 years of experience in computational immunology and holds a Ph.D. in Bioinformatics from Boston University. Since joining EpiVax in 2014, Dr. Richard has developed new computational tools to enhance the immunogenicity...

Close Full biography

Guilhem Richard, CTO, EpiVax Therapeutics

Alexandra Richardson, Executive Director, Institut Clayton de Recherche

×

William Roach, Sr Director of Technology Alliances, ADIMAB LLC

William earned his PhD in Cell and Molecular Biology from Washington University in St. Louis and completed postdoctoral training in Biochemistry at Dartmouth College. He then joined Adimab in 2008 in antibody engineering, focusing on building the platform and executing discovery and engineering...

Close Full biography

William Roach, Sr Director of Technology Alliances, ADIMAB LLC

×

Johan Rockberg, Professor, KTH

Professor in directed evolution and antibody technology at KTH Royal Inst.Technology, Sweden. Director of GeneNova, a center focused on developing platforms for more cost effective, safe and efficacious AAV-based gene therapy through interdisciplinary industry and academia collaborations. He is an...

Close Full biography

Johan Rockberg, Professor, KTH

×

Ali Roghanian, Associate Prof in Cancer Immunotherapy, University of Southampton

Ali Roghanian is an Associate Professor in Cancer Immunotherapy at the University of Southampton, UK. His work bridges basic and translational immunology with a strong focus on developing next‑generation biologics for cancer treatment. Ali’s research centres on understanding how immune pathways can ...

Close Full biography

Ali Roghanian, Associate Prof in Cancer Immunotherapy, University of Southampton

×

Agatha Rosenthal, Market Development Manager, Malvern Panalytical GmbH

Dr. Agatha Rosenthal studied Chemistry at Heidelberg University. She obtained her PhD in Biophysical Chemistry, researching the properties and interactions of "soft matter" such as biological membranes. After completing her PhD, she moved into industry, working as a Field Application...

Close Full biography

Agatha Rosenthal, Market Development Manager, Malvern Panalytical GmbH

×

Alexis Rossignol, Project Manager in analytical development and validation, Clean Cells – Naobios

Alexis Rossignol earned his PhD in 2007 on the theme of anti-tumor immunology from the University of Poitiers (France). He completed his post-doctoral research in a lab dedicated to monoclonal antibodies pharmacogenomics in Tours (France), where he developed in vitro cell-based assays to explore...

Close Full biography

Alexis Rossignol, Project Manager in analytical development and validation, Clean Cells – Naobios

×

Christine Rothe, Chief Development Officer, iOmx Therapeutics AG

Christine Rothe serves as Chief Development Officer at iOmx Therapeutics where she is responsible for research and development programs. Christine has a long-standing track record in discovery and development of drug candidates. Before joining iOmx, Christine held positions of increasing...

Close Full biography

Christine Rothe, Chief Development Officer, iOmx Therapeutics AG

Viacheslav Rusanov, Post-doc researcher, Sanofi R&D

×

Małgorzata Rydzy, Senior Scientist I, Selvita

Małgorzata Rydzy, PhD is a Senior Scientist specializing in antibody biophysical characterization and developability. She has four years of industry experience in a CRO environment, where she focuses on delivering high‑quality, client‑driven projects.Her expertise includes assessing physicochemical ...

Close Full biography

Małgorzata Rydzy, Senior Scientist I, Selvita

Rahul Saikia, Chief Strategy Officer, Rising Pharmaceuticals

×

Akanksha Saini, Research Scientist, Indian Institute of Technology Delhi

Akanksha Saini is a Research Scientist at the Indian Institute of Technology Delhi, with a PhD in Biological Sciences and a strong foundation in virology, biophysics, and neurodegenerative disease research. Her work has focused on leveraging viral systems both as therapeutic tools and as models to...

Close Full biography

Akanksha Saini, Research Scientist, Indian Institute of Technology Delhi

×

Moin Saleem, Founder & CSA, Purespring Therapeutics

Professor Saleem trained as an undergraduate at University College, London. Paediatric nephrology training at Great Ormond Street Hospital, London. He set up his independent laboratory programme in glomerular cell biology in Bristol, as well as holding a post as a consultant paediatric nephrologist ...

Close Full biography

Moin Saleem, Founder & CSA, Purespring Therapeutics

Stefano Sammicheli, Senior Director, Ichnos Glenmark Innovation

Marie-Laure Santiago-Raber, CSO, ACLRT.Bio

×

Alejandro Sanz Garcia, PKPD modeler, LYO-X AG

Alejandro Sanz Garcia is an expert for the PK/PD and QSP supported development of antibody–drug conjugates, T cell engagers, cell therapies, and other advanced modalities across multiple therapeutic indications. He focuses on leveraging preclinical data to enable safe first-in-human and efficacious ...

Close Full biography

Alejandro Sanz Garcia, PKPD modeler, LYO-X AG

Krishna Sarikonda, Regulatory CMC Director, RezonBio

Andreas Schaaf, CSO, eleva GmbH

×

Carina Schey, CEO, Shout

Carina Schey has many years of both pharmaceutical industry and clinical pharmacy experience. With a doctorate awarded by the University of Groningen, Carina’s experience span across the healthcare ecosystem, clinical development, health technology assessment, and reimbursement strategy. After...

Close Full biography

Carina Schey, CEO, Shout

Benoit Schmidt, CBO, ACLRT.Bio

Kai-Thomas Schneider, Group Leader, Antibody Switch Technologies, T.U. Braunschweig

×

Jan Schnitzer, Director, P.R.I.S.M.

PRISM was founded in 2009 by Dr. Schnitzer, a world-renowned expert in vascular biology with almost four decades of research experience.  Upon earning his MD in 1985 from the University of Pittsburgh, he served as a Post-Doctoral Fellow in the Department of Cell Biology, Yale University Medical...

Close Full biography

Jan Schnitzer, Director, P.R.I.S.M.

×

Thomas Schwarz, Head Customer Liaison & Quality Strategy, SKAN AG

Thomas Schwarz has started his career at the former Hoechst AG in the area of recombinant insulin production in 1999. In more than 25 years, working at different international pharma companies (sanofi, Novartis, Takeda), he has acquired detailed knowledge in the areas of biologics drug substance...

Close Full biography

Thomas Schwarz, Head Customer Liaison & Quality Strategy, SKAN AG

Andreas Seidl, CSO, Formycon AG

×

Oliver Seifert, Post-Doc, University of Stuttgart

Oliver Seifert is a senior scientist in the laboratory of Roland Kontermann at the University of Stuttgart and leads the bispecific antibody group. He is an expert in the field of antibody engineering with more than 20 years experience. His scientific research covers development and...

Close Full biography

Oliver Seifert, Post-Doc, University of Stuttgart

Aridni Shah, Co-Founder and Chief Executive Officer, immunitoAI Private Limited

Daya Shankar, Dean, School of Sciences and Founder SuktiAI, Woxsen University

Alexander Sherman, Director, Center for Innovation and Bioinformatics, Mass General Hospital, Harvard Medical School

×

Arne Skerra, Professor, TU Munich

Dr. Arne Skerra is Full Professor at the Technical University of Munich in the School of Life Sciences. He started his scientific career in the field of protein engineering, where he pioneered the biosynthesis of functional antibody fragments in E. coli. Apart from several other contributions to...

Close Full biography

Arne Skerra, Professor, TU Munich

×

Jae Sly, CEO, Pathways Preclinical Partners

Dr. Sly has over 25 years of experience in biomanuacturing, spanning across R&D to clinical production. Dr. Sly has established a wide network of collaborators in the bioprocessing Industry, including patent-holding biopharmaceutical companies, contract research organizations (CROs), and...

Close Full biography

Jae Sly, CEO, Pathways Preclinical Partners

Elizaveta Solovyeva, Senior Expert Data Scientist, Novartis

Benjamin Sommer, Associate Director USP Development, Novartis

Andreas Stengl, Team Lead, Protein Engineering, Ludwig Maximilians University Munich

Christian Stocker, Scientist, ANAVEON AG

Lorenz Tanner, Member of Patient Advisory Board, PPIE in Switzerland, the Patient Advisory Board of the Swiss Cancer Institute

Nazanin Tatari, Post-Doctoral Fellow, University Hospital Basel

×

Anike Te, Chief Strategy Officer; Aegis Professor of Engineering Biology, Lucideon

Anike Te is an industrial strategist, honorary professor, and advisor focused on long-term strategic growth and innovation. She was appointed Chief Strategy Officer of Lucideon Group in 2018, previously served on the Group Business Development Board and is now a member of the Strategy Management...

Close Full biography

Anike Te, Chief Strategy Officer; Aegis Professor of Engineering Biology, Lucideon

×

Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions

Bert is currently Senior Vice President, Business Development of Bio-Thera Solutions, a China-based pharmaceutical company, joining the company in 2017. Prior to joining Bio-Thera Solutions, Bert was the CEO of the Sarcoma Foundation of America (SFA), a rare cancer patient advocacy...

Close Full biography

Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions

×

Jakub Tomala, Assistant Research Professor, John Hopkins University

Dr. Jakub Tomala earned his Master Science degree and Ph.D., both in Immunology, at Charles University in Prague, Czech Republic. After completing a postdoctoral fellowship at Johns Hopkins University, School of Medicine, in 2018, Dr. Tomala became senior researcher in the Laboratory of...

Close Full biography

Jakub Tomala, Assistant Research Professor, John Hopkins University

×

Darren Tomlinson, Professor, University of Leeds

Professor Darren Tomlinson is Head of the School of Molecular and Cellular Biology at the University of Leeds and co-inventor of the Adhiron protein scaffold, a versatile engineered binding platform widely used in research and diagnostics. His work focuses on protein engineering approaches that...

Close Full biography

Darren Tomlinson, Professor, University of Leeds

×

Olivier Tramis, Senior Research Scientist, University of Strasbourg

Dr. Tramis is a specialist of formulation of biomaterials, bringing eco-friendly and innovative solutions to streamline the delivery and preservation of biologics, from peptides to cells

Close

Olivier Tramis, Senior Research Scientist, University of Strasbourg

Thi Hong Hue Tran, PhD candidate - Antibody Discovery & Protein Engineering, Merck Healthcare KGaA

×

Marco Traub, Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society

Dr. Marco Traub has gained considerable experience in several research, management, and educational projects over the past 25 years. He is the founder of the Trans European Stem Cell Therapy Consortium (TESCT) and acts since 2005 as Chair of the TESCT consortium and as EU-Commission Expert...

Close Full biography

Marco Traub, Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society

Matthew Turner, Government affairs and Biosimilar Policy expert, Independant

×

Laura Unmuth, Bench Scientist & PhD candidate - Antibody Discovery & Protein Engineering, Merck KGaA

Laura Unmuth is a Bench Scientist and PhD candidate in the Antibody Discovery & Protein Engineering department of Merck KGaA, supervised by Stefan Zielonka and in collaboration with the group of Prof. Dr. Harald Kolmar at the Technical University of Darmstadt. Her research work focuses on the...

Close Full biography

Laura Unmuth, Bench Scientist & PhD candidate - Antibody Discovery & Protein Engineering, Merck KGaA

×

Stefanie Urlinger, CSO, Cimeio Therapeutics

Stefanie Urlinger is Chief Scientific Officer at Cimeio Therapeutics, a biotech company developing state-of-the-art immunotherapies, along with paired, engineered hematopoietic stem cells. Stefanie has over 20 years of expertise in large molecule engineering and early development and has led...

Close Full biography

Stefanie Urlinger, CSO, Cimeio Therapeutics

Tom Valentin, Group Leader - Automated Sample Handling, CSEM SA

×

Thomas Valerius, Assistant Professor, Section For Stem Cell Transplantation and Immunotherapy, University of Kiel

Thomas Valerius studied medicine at the University of Erlangen-Nürnberg, Germany. After his training in Internal Medicine, he specialized in Hematology/Oncology and Rheumatology. Since May 2003, he has been working at the University in Kiel, Germany, where he currently is assistant professor at the ...

Close Full biography

Thomas Valerius, Assistant Professor, Section For Stem Cell Transplantation and Immunotherapy, University of Kiel

Tom Van Bogaert, Project Head Innovation, Sanofi

×

Erik van den Berg, CEO, Memo-Therapeutics AG

Erik van den Berg is the CEO of Memo Therapeutics AG, bringing over 25 years of industry experience and a proven track record in leadership and company growth. He is the former CEO of AM-Pharma and holds chairmanships in Step Pharma and TargED Therapeutics and was the co-founder and (executive)...

Close Full biography

Erik van den Berg, CEO, Memo-Therapeutics AG

Lore Van Oudenhove, CTO, myNEO Therapeutics

Anna Vangone, AI Leader, Roche

Micaela Vitor, Senior Scientist, sanofi

×

Annette Vogl, VP, Biology and Translational Research, Tubulis GmbH

2015-2020: Scientist at Genentech,Since 2020: Head of Biology / VP, Biology and Translational Research at TubulisScientific training background: molecular cell biology, protein degradation, cellular protein homeostasis

Close

Annette Vogl, VP, Biology and Translational Research, Tubulis GmbH

×

Johannes vom Berg, PI, University of Zurich

Johannes vom Berg is a group leader at the Institute of Laboratory Animal Science (LTK), University of Zurich, Switzerland since 2019. Before that his main occupation was to direct the LTK transgenic mouse core facility of the University of Zurich from 2014-2018. He studied biology and molecular...

Close Full biography

Johannes vom Berg, PI, University of Zurich

×

Moritz von Stosch, Partner and Founder, HINA Bioventures

Dr. Moritz von Stosch is Partner & Founder at HINA Bioventures. He is a thought leader in digital bioprocessing and works at the intersection of bioprocess development, digital technologies, and investment, with a focus on applying AI and advanced data-driven methods to improve the design and...

Close Full biography

Moritz von Stosch, Partner and Founder, HINA Bioventures

Arnold Vulto, Honorary Professor in Hospital Pharmacy, Erasmus MC

Nicole Wagner, Founder of LambdaVision, Lambdavision

John Wang, Chief Scientific Officer, Kali Therapeutics

Yannik Weber, AbbVie

×

Ronnie Wei, Head of Biologics Discovery and Development, ModeX Therapeutics

Ronnie R. Wei, PhD, MBA is a biopharmaceutical executive with nearly 20 years of experience in biologics discovery and early-stage drug development, specializing in oncology, immune-oncology, and infectious diseases. She currently leads Biologics Discovery and Development at ModeX...

Close Full biography

Ronnie Wei, Head of Biologics Discovery and Development, ModeX Therapeutics

×

Leon Willis, Postdoctoral Fellow, University of Leeds

Dr Leon F Willis MRSC is postdoctoral research fellow at the Astbury Centre for Structural Molecular Biology, University of Leeds. He is currently researcher co-investigator on an EPSRC-funded grant, supervised by Prof David Brockwell, Prof Sheena Radford OBE FRS FMedSci and Prof Nik Kapur, as well ...

Close Full biography

Leon Willis, Postdoctoral Fellow, University of Leeds

×

Jörg Wischhusen, Professor, Universitätsklinikum Würzburg

Jörg Wischhusen studied biochemistry in Tübingen, Germany. During his thesis on mechanisms of immune escape in glioma (mentored by Michael Weller and Hans-Georg Rammensee) he performed early work in the field of experimental immune checkpoint blockade. In 2005 he was recruited as a junior research...

Close Full biography

Jörg Wischhusen, Professor, Universitätsklinikum Würzburg

Frederick Wittke, CEO and Founder, Arthama GmbH

×

Armin Wolf, Strategic Tox Consultant, awoCON

Armin Wolf is the founder of awoCON, a consulting compang speializing in translational drug safety, providing scientific and strategic solutions to biotechs and pharma companies. He is Professor of Toxicology in Drug Discovery and Developemnt at the Technical University of...

Close Full biography

Armin Wolf, Strategic Tox Consultant, awoCON

×

Yi-Ru Yu, Lead Scientist, Pilatus Biosciences SA

Dr. Yi-Ru Yu is currently a Senior Scientist at Pilatus Biosciences SA. He obtained his B.S. in Life Science and M.S. in Genomic Science from National Yang-Ming University in 2008. Dr. Yu then pursued a Ph.D. in Prof. Chun-Ming Chen's lab, where his research focused on the congenital diseases...

Close Full biography

Yi-Ru Yu, Lead Scientist, Pilatus Biosciences SA

×

Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo

My passion are science and people. Hence,  it appealed to me to study medicine and following undergraduate studies in Berlin, I went into surgery in the UK and Germany,  and eventually I found my passion in surgical oncology, caring for patients with breast cancer, sarcoma, melanoma and many other...

Close Full biography

Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo

Dénes Zalai, Director Technology, Eleva Gmbh

×

Zenon Zenonos, Associate Director B-Cell Technology, AstraZeneca

Zenon is leading the B-Cell Technology Team at AstraZeneca in Cambridge. His team is specializing in antibody discovery using single-cell technologies. His work focuses on integrating wet lab and in silico approaches to accelerate therapeutic antibody lead generation. Zenon's research...

Close Full biography

Zenon Zenonos, Associate Director B-Cell Technology, AstraZeneca

×

Sam Zhang, VP of Biologics Development & Manufacturing, WuXi Biologics

Sam Zhang, PhD, has over 17 years of industry experience in rProtein expression, cell line and process development, and CMC management. In his current role as Vice President and Head of Microbial and Viral Platforms at WuXi Biologics, Sam leads innovative efforts across microbial, mRNA/LNP, and...

Close Full biography

Sam Zhang, VP of Biologics Development & Manufacturing, WuXi Biologics

×

Jay Zhao, Chief Technology Officer, Kali Therapeutics

Jay Zhao, Ph.D oversees Kali’s CMC strategy and GMP manufacturing, and drives technology platform innovation. Dr. Zhao brings nearly 20 years of experience across antibodies, immunotoxins, vaccines, and conjugation technologies.  Before co-founding Kali, Dr. Zhao served as Vice President of...

Close Full biography

Jay Zhao, Chief Technology Officer, Kali Therapeutics